BTAI
Price
$0.34
Change
-$0.01 (-2.86%)
Updated
Jan 17 closing price
Capitalization
17.07M
47 days until earnings call
COGT
Price
$8.03
Change
-$0.10 (-1.23%)
Updated
Jan 17 closing price
Capitalization
887.01M
59 days until earnings call
Ad is loading...

BTAI vs COGT

Header iconBTAI vs COGT Comparison
Open Charts BTAI vs COGTBanner chart's image
BioXcel Therapeutics
Price$0.34
Change-$0.01 (-2.86%)
Volume$896.02K
Capitalization17.07M
Cogent Biosciences
Price$8.03
Change-$0.10 (-1.23%)
Volume$1.16M
Capitalization887.01M
BTAI vs COGT Comparison Chart
Loading...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BTAI vs. COGT commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BTAI is a Hold and COGT is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (BTAI: $0.34 vs. COGT: $8.03)
Brand notoriety: BTAI and COGT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BTAI: 86% vs. COGT: 70%
Market capitalization -- BTAI: $17.07M vs. COGT: $887.01M
BTAI [@Biotechnology] is valued at $17.07M. COGT’s [@Biotechnology] market capitalization is $887.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BTAI’s FA Score shows that 0 FA rating(s) are green whileCOGT’s FA Score has 0 green FA rating(s).

  • BTAI’s FA Score: 0 green, 5 red.
  • COGT’s FA Score: 0 green, 5 red.
According to our system of comparison, COGT is a better buy in the long-term than BTAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BTAI’s TA Score shows that 3 TA indicator(s) are bullish while COGT’s TA Score has 5 bullish TA indicator(s).

  • BTAI’s TA Score: 3 bullish, 6 bearish.
  • COGT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, COGT is a better buy in the short-term than BTAI.

Price Growth

BTAI (@Biotechnology) experienced а -8.83% price change this week, while COGT (@Biotechnology) price change was +2.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

BTAI is expected to report earnings on May 12, 2025.

COGT is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($887M) has a higher market cap than BTAI($17.1M). COGT YTD gains are higher at: 2.949 vs. BTAI (-7.997). BTAI has higher annual earnings (EBITDA): -56.15M vs. COGT (-256.4M). COGT has more cash in the bank: 336M vs. BTAI (40.4M). COGT has less debt than BTAI: COGT (17.8M) vs BTAI (105M). BTAI has higher revenues than COGT: BTAI (2.28M) vs COGT (0).
BTAICOGTBTAI / COGT
Capitalization17.1M887M2%
EBITDA-56.15M-256.4M22%
Gain YTD-7.9972.949-271%
P/E RatioN/AN/A-
Revenue2.28M0-
Total Cash40.4M336M12%
Total Debt105M17.8M590%
FUNDAMENTALS RATINGS
BTAI vs COGT: Fundamental Ratings
BTAI
COGT
OUTLOOK RATING
1..100
7218
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
80
Overvalued
PROFIT vs RISK RATING
1..100
10060
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9555
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COGT's Valuation (80) in the Miscellaneous industry is in the same range as BTAI (82) in the Biotechnology industry. This means that COGT’s stock grew similarly to BTAI’s over the last 12 months.

COGT's Profit vs Risk Rating (60) in the Miscellaneous industry is somewhat better than the same rating for BTAI (100) in the Biotechnology industry. This means that COGT’s stock grew somewhat faster than BTAI’s over the last 12 months.

COGT's SMR Rating (98) in the Miscellaneous industry is in the same range as BTAI (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to BTAI’s over the last 12 months.

COGT's Price Growth Rating (55) in the Miscellaneous industry is somewhat better than the same rating for BTAI (95) in the Biotechnology industry. This means that COGT’s stock grew somewhat faster than BTAI’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as BTAI (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to BTAI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BTAICOGT
RSI
ODDS (%)
Bearish Trend 5 days ago
79%
Bullish Trend 5 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
88%
Momentum
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
85%
MACD
ODDS (%)
Bullish Trend 5 days ago
87%
Bullish Trend 5 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
85%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 12 days ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 5 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
85%
Bullish Trend 5 days ago
77%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
81%
View a ticker or compare two or three
Ad is loading...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

BTAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BTAI has been loosely correlated with SYBX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BTAI jumps, then SYBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BTAI
1D Price
Change %
BTAI100%
-0.52%
SYBX - BTAI
39%
Loosely correlated
+0.69%
SBHMY - BTAI
32%
Poorly correlated
N/A
COGT - BTAI
31%
Poorly correlated
-1.23%
CRMD - BTAI
29%
Poorly correlated
-4.85%
JSPR - BTAI
29%
Poorly correlated
+3.18%
More

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with HOFBF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-1.23%
HOFBF - COGT
63%
Loosely correlated
N/A
TNFA - COGT
55%
Loosely correlated
-2.52%
ENGN - COGT
45%
Loosely correlated
+1.85%
KROS - COGT
41%
Loosely correlated
+3.23%
NTLA - COGT
36%
Loosely correlated
+0.85%
More